$CRVS Corvus Pharmaceuticals, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Corvus Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Corvus Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Corvus Pharmaceuticals, Inc. for free.
IRS Number: 464670809
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: CRVS
Company Address: 863 MITTEN ROAD SUITE 102 BURLINGAME 94010
Phone number: (650) 900-4520
Market Capitalization: $293.59M
Prev close: $13.83
Average Daily Volume: 20,555
Days Low: $13.85
Year Low: $9.63
Year High: $17.77
Corvus Pharmaceuticals, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16 2021 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | A | 2.74 | 15,000 | 41,100 | 15,000 | |
| May 05 2021 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Buy | P | 2.80 | 35,714 | 99,999 | 35,714 | 0 to 35.7 K |
| Feb 19 2021 | CRVS | Corvus Pharmaceuti ... | ORBIMED ADVISORS LLC | Director | Buy | P | 3.50 | 1,285,714 | 4,499,999 | 8,053,298 | 6.8 M to 8.1 M (+19.00 %) |
| Feb 19 2021 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Buy | P | 3.50 | 1,285,714 | 4,499,999 | 8,053,298 | 6.8 M to 8.1 M (+19.00 %) |
| Dec 17 2020 | CRVS | Corvus Pharmaceuti ... | Jones William Benton | See Remarks | Option Exercise | A | 4.01 | 160,000 | 641,600 | 160,000 | |
| Dec 17 2020 | CRVS | Corvus Pharmaceuti ... | LEA LEIV | Chief Financial Off ... | Option Exercise | A | 4.01 | 160,000 | 641,600 | 160,000 | |
| Dec 17 2020 | CRVS | Corvus Pharmaceuti ... | MILLER RICHARD A MD | President and CEO | Option Exercise | A | 4.01 | 320,000 | 1,283,200 | 320,000 | |
| Dec 17 2020 | CRVS | Corvus Pharmaceuti ... | Mobasher Mehrdad | SVP, Chief Medical ... | Option Exercise | A | 4.01 | 85,000 | 340,850 | 85,000 | |
| Sep 15 2020 | CRVS | Corvus Pharmaceuti ... | Mitchell Edith P. | Director | Option Exercise | A | 3.95 | 30,000 | 118,500 | 30,000 | |
| Jul 09 2020 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 5.37 | 741,440 | 3,985,166 | 1,389,498 | 2.1 M to 1.4 M (-34.79 %) |
| Jul 09 2020 | CRVS | Corvus Pharmaceuti ... | Novo Holdings A/S | 10% Owner | Sell | S | 5.25 | 796,622 | 4,183,381 | 2,130,938 | 2.9 M to 2.1 M (-27.21 %) |
| Jun 15 2020 | CRVS | Corvus Pharmaceuti ... | ADAMS STREET PARTNERS LLC | 10% Owner | Option Exercise | A | 3.27 | 15,000 | 49,050 | 15,000 | |
| Jun 12 2020 | CRVS | Corvus Pharmaceuti ... | Thompson Peter A. | Director | Option Exercise | A | 3.27 | 15,000 | 49,050 | 15,000 | |
| Jun 12 2020 | CRVS | Corvus Pharmaceuti ... | Morrison Scott W | Director | Option Exercise | A | 3.27 | 15,000 | 49,050 | 15,000 | |
| Jun 12 2020 | CRVS | Corvus Pharmaceuti ... | Krognes Steve E. | Director | Option Exercise | A | 3.27 | 15,000 | 49,050 | 15,000 |